CMB 401
Alternative Names: anti-PEM monoclonal antibody calicheamicin; CDP 671; hcT.MO1 calicheamicin; hCTMO1-calicheamicin; LLE 33288Latest Information Update: 02 Feb 2000
At a glance
- Originator Celltech Group
- Class Cytostatic antibiotics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-small cell lung cancer; Ovarian cancer
Most Recent Events
- 02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group
- 16 Dec 1999 Investigation in Non-small cell lung cancer in United Kingdom (IV-infusion)
- 16 Dec 1999 Investigation in Non-small cell lung cancer in USA (IV-infusion)